Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 6Genitourinary 5Gastrointestinal 5Breast 4Other hematologic neoplasm 2Dermatologic 2CNS 2NET 1Lymphoid 1Gynecologic 1Endocrine 1

Conditions

Melanoma 688Lymphoma, T-Cell, Cutaneous 116Keratosis, Actinic 109Skin Neoplasms 99Carcinoma, Non-Small-Cell Lung 81Mycosis Fungoides 79Neoplasm Metastasis 78Neoplasms 75Sezary Syndrome 74Lymphoma, Non-Hodgkin 72Leukemia, Lymphocytic, Chronic, B-Cell 65Lymphoma, Follicular 64Lymphoma, Large B-Cell, Diffuse 63Lymphoma, B-Cell, Marginal Zone 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 59Lymphoma, Mantle-Cell 59Uveal Melanoma 58Carcinoma, Renal Cell 58Carcinoma, Basal Cell 58Lymphoma, Large-Cell, Immunoblastic 56Hodgkin Disease 56Burkitt Lymphoma 55Lymphoma 52Lymphoma, Large-Cell, Anaplastic 50Waldenstrom Macroglobulinemia 44Multiple Myeloma 44Lymphoma, Extranodal NK-T-Cell 44Breast Neoplasms 44Immunoblastic Lymphadenopathy 43Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 41

Interventions

Diagnosis, Computer-Assisted 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Disease × Dermatologic × Clear all
NCT06221397 2026-03-16

LEGIT_MC_EVCDA

AI Labs Group S.L

Completed
105 enrolled 15 charts
Dermatologic

Disease, Melanoma

NCT05578872 2025-08-26

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

Anaveon AG

Phase 1/2 Completed
29 enrolled 15 charts
Dermatologic

Disease, Melanoma, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡